LNSR
LENSAR, Inc. [LNSR] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
LNSR Stock Summary
Top 10 Correlated ETFs
LNSR
Top 10 Correlated Stocks
LNSR
In the News
LNSR Financial details
Company Rating
-
Market Cap
37.38M
Income
-14.57M
Revenue
42.16M
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
130
Optionable
No
Shortable
Yes
Earnings
13 May 2024
P/E
-3.32
Forward P/E
-
PEG
1.1
P/S
1.16
P/B
1.26
P/C
-
P/FCF
-3.28
Quick Ratio
2.64
Current Ratio
4.42
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-1.35
EPS next Y
-
EPS next Q
-
EPS this Y
-32.12%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-3.56%
Revenue last 5Y
6.67%
Revenue Q/Q
23.58%
EPS Q/Q
-252.17%
-
-
-
-
SMA20
1.42%
SMA50
-2.56%
SMA100
-51.86%
Inst Own
-
Inst Trans
-
ROA
-20%
ROE
-37%
ROC
-0.2%
Gross Margin
56%
Oper. Margin
-29%
Profit Margin
-34%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
1.8-5.3
52W High
+16.4%
52W Low
+482%
RSI
51.12
Rel Volume
0.63
Avg Volume
44.33K
Volume
27.86K
Perf Week
1.39%
Perf Month
11.28%
Perf Quarter
-51.54%
Perf Half Y
-49.61%
-
-
-
-
Beta
0.47
-
-
Volatility
0.09%, 0.19%
Prev Close
0%
Price
5.82
Change
2.65%
Company Profile
- Volume Average 44.33K
- Market Capitalization 37.38M
- Employee 130
- CEO Mr. Nicholas T. Curtis
- Headquarters Orlando,FL,US
- IPO Date 2020-10-02
-
Website
https://www.lensar.com 
LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. Its LENSAR Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, procedure planning, design, and precision. The company was incorporated in 2004 and is headquartered in Orlando, Florida.
